Clinical Trial Update: Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 study assessing how ketoconazole affects the pharmacokinetics of cediranib in patients with solid tumors to evaluate potential drug-drug interactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Cediranib (Cediranib)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED